Beam Therapeutics Inc. · NASDAQ:BEAM

Dapice Joshua J. reported a 9.90% stake in Beam Therapeutics Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 5, 2025

Dapice Joshua J. reported a 9.90% stake in Beam Therapeutics Inc., 8,239,123 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
8,239,123
Intent
Passive
What changed
Stake changed
Filed together
30 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.70%574,427
Farallon Capital Institutional Partners, L.P.0.80%696,172
Farallon Capital Institutional Partners II, L.P.0.20%193,998
Farallon Capital Institutional Partners III, L.P.0.10%84,368
Four Crossings Institutional Partners V, L.P.0.20%124,235
Farallon Capital Offshore Investors II, L.P.1.70%1,387,018
Farallon Capital (AM) Investors, L.P.0.10%79,868
Farallon Capital F5 Master I, L.P.0.40%304,036
Farallon Healthcare Partners Master, L.P.5.80%4,795,001
Farallon Partners, L.L.C.9.60%7,935,087
Farallon Institutional (GP) V, L.L.C.0.20%124,235
Farallon F5 (GP), L.L.C.0.40%304,036
Farallon Healthcare Partners (GP), L.L.C.5.80%4,795,001
Dapice Joshua J.9.90%8,239,123
Dreyfuss, Philip D.9.90%8,239,123
Dunn Hannah E.9.90%8,239,123
Fried, Richard B9.90%8,239,123
Gehani, Varun N.9.90%8,239,123
Giauque, Nicolas9.90%8,239,123
Kim, David T.9.90%8,239,123
Linn, Michael G.9.90%8,239,123
Luo Patrick (Cheng)9.90%8,239,123
Patel, Rajiv A.9.90%8,239,123
Roberts, Jr., Thomas G.9.90%8,239,123
Saito Edric C.9.90%8,239,123
Seybold, William9.90%8,239,123
Short Daniel S.9.90%8,239,123
Spokes, Andrew J. M.9.90%8,239,123
Warren, John R.9.90%8,239,123
Wehrly, Mark C.9.90%8,239,123

Source

View original at SEC

Related